The future is now: beyond first line systemic therapy in hepatocellular carcinoma.

Authors:
Nenu I; Breaban I; Pascalau S; Bora CN; Stefanescu H.

Journal:
Transl Cancer Res

Publication Year: 2019

DOI:
10.21037/tcr.2018.11.23

PMCID:
PMC8797356

PMID:
35117106

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: Transl Cancer Res

Detailed journal information not available.

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

2/6

0.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tcr.2018.11.23). The series “Primary Liver Cancer” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare."

Funding Disclosure

Evidence found in paper:

"Funding: I Nenu and H Stefanescu were partially supported by the PN-III-P1-1.2-PCCDI-2017-0221/59PCCDI/2018 (IMPROVE) project ."

Protocol Registration

Open Access

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025